Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Purpose. To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. Methods. Patients were divided into two groups. All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2–0.5 mL of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Deli Krizova, Magdalena Vokrojova, Katerina Liehneova, Pavel Studeny
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2014/178132
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hybrid Technique of Lamellar Keratoplasty (DMEK-S)
by: Pavel Studeny, et al.
Published: (2013-01-01)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
by: Belghmaidi Sarah, et al.
Published: (2016-01-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
by: Sónia Torres-Costa, et al.
Published: (2022-01-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
by: Sertan Goktas, et al.
Published: (2014-01-01)

Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages
by: Junki Kwon, et al.
Published: (2017-01-01)

Chemical, Physical, and Biological Corneal Decellularization Methods: A Review of Literature
by: Alexandra Procházková, et al.
Published: (2024-01-01)

Anti-VEGF Treatment Strategies for Wet AMD
by: Jaclyn L. Kovach, et al.
Published: (2012-01-01)

Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage
by: Hua Yan
Published: (2016-01-01)

Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study
by: Christof Haensli, et al.
Published: (2021-01-01)

Use of Anti-VEGF Agents in Glaucoma Surgery
by: Mark Slabaugh, et al.
Published: (2017-01-01)

Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Jianqing Li, et al.
Published: (2018-01-01)

Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen
by: Alexandra Miere, et al.
Published: (2018-01-01)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
by: Junko Yoshida, et al.
Published: (2015-01-01)

Anti-VEGF Cancer Therapy in Nephrology Practice
by: Hassan Izzedine
Published: (2014-01-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report
by: Hassaan Asif, et al.
Published: (2022-01-01)

Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
by: Pearse A. Keane, et al.
Published: (2012-01-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
by: Robert Hodgson, et al.
Published: (2025-01-01)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01)

Human Platelets Take up Anti-VEGF Agents
by: B. Sobolewska, et al.
Published: (2021-01-01)

Anti-VEGF in a Marathon Runner’s Retinopathy Case
by: Alexander Kahjun Soon, et al.
Published: (2016-01-01)

Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
by: Mengzhen Xie, et al.
Published: (2024-01-01)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
by: P. ET. Lau, et al.
Published: (2018-01-01)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
by: Caroline Hilmi, et al.
Published: (2012-01-01)

Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01)

Prediction of OCT contours of short-term response to anti-VEGF treatment for diabetic macular edema using generative adversarial networks
by: Xueying Yang, et al.
Published: (2025-04-01)

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography
by: Magdalena Hunt, et al.
Published: (2022-01-01)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01)

Rat Hippocampal Neural Stem Cell Modulation Using PDGF, VEGF, PDGF/VEGF, and BDNF
by: Neus Gomila Pelegri, et al.
Published: (2019-01-01)

Bevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab
by: Jeevan Kumar, et al.
Published: (2012-01-01)

Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
by: Ernest V. Boiko, et al.
Published: (2017-01-01)

Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
by: Ya-Jui Hsu, et al.
Published: (2014-01-01)

The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury
by: Xiao Zhao, et al.
Published: (2021-01-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
by: Pedro Neves Cardoso, et al.
Published: (2017-01-01)